While LUCAT1 regulates NF-KB signaling in chronic obstructive pulmonary disease (COPD) or inflammatory bowel disease (IBD), its specific involvement in cancer-related NF-KB signaling remains unknown [59]. Here, NFKB1 is linked to cancer.